Global Artificial Sperm Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2024-2030: The artificial sperm market is set to grow due to increasing chronic illness rates, higher disability prevalence, and longer life expectancies, which drive demand for long-term care facilities, among other factors.
Global Artificial Sperm Market is valued at USD XX Billion in 2024 and it is expected to generate absolute dollar opportunity of USD XX Billion by 2030 with a CAGR of XX% over the forecast period.
Artificial insemination is a method of fertilization in which sperm is implanted directly into the female reproductive system using medical procedures. It is usually done with donor sperm or fresh or frozen sperm and can be done in a variety of ways, including intracervical, intrauterine, or intravaginal procedures. Furthermore, an easy method for keeping human sperm using glycerol was introduced in 1953 by Dr. Jerome K. Sherman, an innovator in sperm freezing in the United States.
Artificial sperm reduces the chance of any disorder being transmitted to the child by a parent. Apart from this, single women can use these spermatozoa to fertilize their own oocytes, and same-sex female couples can have offspring that carry the genetic information from both female partners.
The COVID-19 epidemic has significantly impacted the financial health of businesses in various industries, including fertility clinics involved in artificial sperm research. Due to the pandemic, some research laboratories had to close or limit their activities, leading to challenges and increased research costs. In response, reproductive clinics and laboratories have implemented additional safety rules to protect their employees and patients while striving to meet the needs of infertile patients worldwide. Despite the obstacles, organizations like the Fertility Centers of New England remain committed to providing infertility treatments while adhering to regulatory guidelines set by the American Society of Reproductive Medicine. Donor sperm plays a crucial role in these efforts.
On 04th -Aug-2022, According to the study, scientists have created the world's first fertilized synthetic sperm using stem cells developed in a controlled environment. This remarkable achievement eliminates the requirement for fertilized eggs and traditional sperm, opening new possibilities in the realm of artificial sperm.
On 06th-Jun-2022 Using modern microchip technology and a clever microfluidic technique, Israeli scientists have manufactured functioning sperm. This ground-breaking discovery has enormous potential for solving reproductive issues and revolutionizing the artificial sperm business.
The market for Artificial sperm, along with its substitutes, is expected to grow significantly due to advancements in reproductive technology. Research institutes and academic centers are actively exploring the use of in vitro Fertilization (IVF) artificial sperm to treat male infertility, strengthening their position in the market. Some scientists in the United States and the United Kingdom have achieved a breakthrough by creating structures resembling human embryos using stem cells, bypassing the need for traditional eggs and sperm. As well, recent research explains that demand for IVF treatments has steadily increased. In 2019, almost 53,000 patients had 69,000 fresh and frozen IVF cycles and 5,700 DI cycles at HFEA licensed fertility clinics in the United Kingdom. Additionally, the growth in IVF cycles has stabilised since 2017, but frozen embryo transfers continue to increase year on year, increasing 86% from 2014-2019. This remarkable progress is driving further growth in the field of infertility treatments, with in vitro Fertilization (IVF) playing a crucial role.
The artificial sperm market's growth could be slowed down by concerns about ethics, strict rules, and safety uncertainties, especially in male infertility and insemination procedures. The high costs and limited awareness may make it hard for many people to access and accept these technologies. For example, according to the report articles, without insurance, intrauterine insemination costs around US$300 to US$1,000 per cycle. Some individuals may prefer traditional methods, and there could be emotional and cultural barriers as well.
In North America, the artificial semen market is expected to grow rapidly due to an increase in the prevalence of azoospermia, a disorder that inhibits male fertility. According to the American Society of Reproductive Medicine, 12 to 14% of guys in the United States suffer from azoospermia and require infertility therapy.
The Asia Pacific region is expected to have significant expansion in the global artificial sperm market in the coming years, driven by the development and research efforts being made in artificial sperm by several research institutions in the area. Furthermore, the Chinese Academy of Sciences' Institute of Zoology completed a study on artificial sperm, creating sperm-like cells out of mouse embryonic cells and inserting them into female mouse egg cells. The study revealed that the resulting mice were fertile and had healthy progeny.
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®